StoneX Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,485
Closed -$251K 724
2022
Q1
$251K Buy
3,485
+437
+14% +$31.5K 0.02% 458
2021
Q4
$280K Buy
+3,048
New +$364K 0.03% 430
2021
Q1
Sell
-1,136
Closed -$227K 437
2020
Q4
$227K Buy
+1,136
New +$231K 0.05% 323

Other funds holding TDOC

StoneX Group's TDOC Position: Q2 2022 in Review

StoneX Group sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,485 shares — an estimated $251K sold.

StoneX Group first reported a position in TDOC in Q4 2020 and held it in 3 quarters. The position peaked at $280K in Q4 2021. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • StoneX Group reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • StoneX Group sold 3,485 Teladoc Health shares in Q2 2022, an estimated $251K.
  • StoneX Group first reported a position in Teladoc Health in Q4 2020 and held it in 3 quarters.
  • StoneX Group's Teladoc Health position peaked at $280K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on StoneX Group's 13F filing for Q2 2022, filed 27 Jul 2022.